Consensus Statement on Optimisation of Patient Care After Hospitalisation for Acute Heart Failure - 14/01/26

Doi : 10.1016/j.hlc.2025.09.019

Andrew P. Sindone, MD ^a,^⁎ , John Amerena, MD ^b, Carmine G. De Pasquale, MD ^c, Alicia W.P. Chan, MD ^d, Gary C.H. Gan, MD ^e, Sriram D. Rao, MD ^f, Christine Burdeniuk, MD ^c, Amit Shah, MD ^g, John J. Atherton, MD ^h,ⁱ

^a Concord Hospital and Ryde Hospital, Sydney, NSW, Australia

^b University Hospital Geelong, Vic, Australia

^c Flinders Medical Centre, Adelaide, SA, Australia

^d Royal Adelaide Hospital, Adelaide, SA, Australia

^e Westmead Hospital and Blacktown Hospital, Sydney, NSW, Australia

^f Victorian Heart Hospital and Monash Health, Melbourne, Vic, Australia

^g Fiona Stanley Hospital, Perth, WA, Australia

^h The University of Queensland, Faculty of Medicine, Brisbane, Qld, Australia

ⁱ Cardiology Department, Royal Brisbane and Women’s Hospital, Herston, Qld, Australia

^∗ Corresponding author at: Director Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital and Head of Department of Cardiology, Ryde Hospital, Suite 19, 247 Ryedale Rd, Eastwood, 2122, NSW Australia Director Heart Failure Unit and Department of Cardiac Rehabilitation Concord Hospital and Head of Department of Cardiology Ryde Hospital Suite 19, 247 Ryedale Rd Eastwood NSW 2122 Australia

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Wednesday 14 January 2026

Abstract

Following guideline-directed medical therapy (GDMT) is crucial for managing acute heart failure (AHF). Australia has poor adherence to GDMT with only a small proportion of eligible patients receiving optimal HF therapy. Therefore, there is a real need for unified recommendations to optimise GDMT for patients hospitalised with AHF in Australia. Using a modified DELPHI method, an expert panel of nine Australian clinicians with expertise in HF management convened to develop consensus statements aimed at guiding healthcare professionals in Australia on optimising GDMT. This document outlines a strategy for ensuring patients are started on GDMT while they are in hospital and that GDMT is optimised to maximum tolerated doses rapidly after discharge. This is especially critical because rapid optimisation of heart failure (HF) therapies and close follow-up in the early period after HF hospitalisation has been found to decrease all-cause mortality and reduce the risk of HF readmission. These consensus statements provide a practical framework to help Australian healthcare professionals in optimising GDMT for their patients. This framework is designed to enhance the current AHF guidelines. The consensus statements support the ongoing priority of optimising GDMT for AHF management aiming to ensure that eligible patients receive the optimal therapy for their clinical presentation.

Le texte complet de cet article est disponible en PDF.

Keywords : Guideline-directed medical therapy, Multidisciplinary, Care model, Heart failure